You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

TRIPLE SULFA Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Triple Sulfa, and what generic alternatives are available?

Triple Sulfa is a drug marketed by Alpharma Us Pharms, Fougera, Padagis Us, Purepac Pharm, Pharmaderm, and Lederle. and is included in eight NDAs.

The generic ingredient in TRIPLE SULFA is trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine). Additional details are available on the trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine) profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for TRIPLE SULFA?
What are the global sales for TRIPLE SULFA?
What is Average Wholesale Price for TRIPLE SULFA?

Summary for TRIPLE SULFA

US Patents:	0
Applicants:	6
NDAs:	8
Raw Ingredient (Bulk) Api Vendors:	95
DailyMed Link:	TRIPLE SULFA at DailyMed

Drug patent expirations by year for TRIPLE SULFA

US Patents and Regulatory Information for TRIPLE SULFA

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alpharma Us Pharms	TRIPLE SULFA	triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole)	CREAM;VAGINAL	087864-001	Sep 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Pharmaderm	TRIPLE SULFA	triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole)	TABLET;VAGINAL	088462-001	Jan 3, 1985		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Alpharma Us Pharms	TRIPLE SULFA	trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)	SUSPENSION;ORAL	080280-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Lederle	TRIPLE SULFAS	trisulfapyrimidines (sulfadiazine;sulfamerazine;sulfamethazine)	SUSPENSION;ORAL	006920-003	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Fougera	TRIPLE SULFA	triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole)	CREAM;VAGINAL	086424-001	Approved Prior to Jan 1, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Padagis Us	TRIPLE SULFA	triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole)	CREAM;VAGINAL	087285-001	Nov 15, 1982		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Fougera	TRIPLE SULFA	triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole)	TABLET;VAGINAL	088463-001	Jan 3, 1985		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.